US 12,600,779 · Application 18/515,530 · Granted Apr 14, 2026
US 12,600,779
Lag-3-binding molecules and methods of use thereof
Estimated expiration
June 7, 2036
9y 246d remaining
Earliest effective filing
Jun 7, 2016
+ 20 years
Jun 7, 2036
PTA +0d
Jun 7, 2036
TD applied
Jun 7, 2036
Final
Jun 7, 2036
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- November 21, 2023
- Earliest effective filing
- June 7, 2016
- Issue date
- April 14, 2026
- PTA
- 0 days
- Base expiry (before PTA)
- June 7, 2036
June 7, 2016 + 20 years = June 7, 2036
- Continuation of application 17/147,279, filed Jan 12, 2021, issued as US 11,858,991
- Continuation of application 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
- National stage entry of application PCTUS2016036172, filed Jun 7, 2016
- National stage entry of application PCTUS2016036172, filed Jun 7, 2016
- Continuation of application 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
- National stage entry of application PCTUS2016036172, filed Jun 7, 2016
- PRO62/172,277 — Provisional — not used for base term
- PRO62/255,094 — Provisional — not used for base term
- PRO62/255,094 — Provisional — not used for base term
- PRO62/172,277 — Provisional — not used for base term
- PRO62/255,094 — Provisional — not used for base term
- PRO62/172,277 — Provisional — not used for base term
- PRO62/255,094 — Provisional — not used for base term
- PRO62/172,277 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to June 7, 2036
US 11,072,653· Application 15/580,029Capping patent
Lag-3-binding molecules and methods of use thereof
- Filing date
- Dec 6, 2017
- Earliest effective filing
- Jun 7, 2016
- Issue date
- Jul 27, 2021
- PTA
- +51 days
- Calculated expiration
- Jul 28, 2036
National stage entry of PCTUS2016036172, filed Jun 7, 2016
Jun 7, 2016 + 20y + 51d PTA = Jul 28, 2036
US 11,858,991· Application 17/147,279
Lag-3-binding molecules and methods of use thereof
- Filing date
- Jan 12, 2021
- Earliest effective filing
- Jun 7, 2016
- Issue date
- Jan 2, 2024
- PTA
- +314 days
- Calculated expiration
- Apr 17, 2037
Continuation of 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
National stage entry of PCTUS2016036172, filed Jun 7, 2016
National stage entry of PCTUS2016036172, filed Jun 7, 2016
Jun 7, 2016 + 20y + 314d PTA = Apr 17, 2037
US 12,600,779· Application 18/515,530(from application 18/515,530)Capping patent
Lag-3-binding molecules and methods of use thereof
- Filing date
- Nov 21, 2023
- Earliest effective filing
- Jun 7, 2016
- Issue date
- Apr 14, 2026
- PTA
- 0 days
- Calculated expiration
- Jun 7, 2036
Continuation of 17/147,279, filed Jan 12, 2021, issued as US 11,858,991
Continuation of 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
National stage entry of PCTUS2016036172, filed Jun 7, 2016
National stage entry of PCTUS2016036172, filed Jun 7, 2016
Continuation of 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
National stage entry of PCTUS2016036172, filed Jun 7, 2016
Jun 7, 2016 + 20y = Jun 7, 2036
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 18/515,530 · US 12,600,779
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,600,779: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12600779Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.